Richardson Arlan, Liu Feng, Adamo Martin L, Van Remmen Holly, Nelson James F
Department of Cellular and Structural Biology, Barshop Center for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, 78229, USA.
Best Pract Res Clin Endocrinol Metab. 2004 Sep;18(3):393-406. doi: 10.1016/j.beem.2004.02.002.
Research with invertebrates over the past 10 years has suggested that alterations in insulin and/or insulin-like growth factor I (IGF-I) signalling result in increased lifespan and retard ageing. In this chapter, we describe the current research in mammalian systems with respect to the role of insulin or IGF-I in ageing. Using rodent models of caloric restriction and genetic mouse models, e.g. the Ames and Snell dwarf mice, fat-specific insulin receptor knockout mice (FIRKO) and mice that are heterozygous for the IGF-I receptor (Igf1r+/-), investigators have shown that a reduction in plasma levels of insulin and/or IGF-I or reductions in insulin/IGF-I signalling appear to be correlated with increased longevity and retarded ageing.
过去10年对无脊椎动物的研究表明,胰岛素和/或胰岛素样生长因子I(IGF-I)信号通路的改变会延长寿命并延缓衰老。在本章中,我们描述了目前在哺乳动物系统中关于胰岛素或IGF-I在衰老过程中作用的研究。通过使用热量限制的啮齿动物模型和基因小鼠模型,如艾姆斯侏儒小鼠和斯内尔侏儒小鼠、脂肪特异性胰岛素受体敲除小鼠(FIRKO)以及IGF-I受体杂合子小鼠(Igf1r+/-),研究人员发现,血浆中胰岛素和/或IGF-I水平的降低,或胰岛素/IGF-I信号通路的减弱,似乎与寿命延长和衰老延缓相关。